Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis

Clinical trial NCT04142749 · COMPLETED

Trial details

NCT number: NCT04142749
Sponsor: PharmaKing
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Alcoholic Fatty Liver Disease

Start date: 2019-11-15
Primary completion: 2022-09-02
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.